InspireMD, Inc. — Director's Dealing 2025

Jun 27, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-06-25

Reporting Person: Lawless Michael A (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	465000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock (right to buy)	$2.24	2035-06-25	Common Stock (212000)		Direct

Footnotes

F1: These shares of common stock represent 465,000 shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service.

F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service.